NANO-DITECH CORPORATION

Nano-Ditech Corporation is a manufacturer of rapid immunodiagnostic products for point-of-care and in vitro diagnostic testing. The company specializes in the development and manufacturing of lateral flow immunoassay-based diagnostic tests for infectious diseases and cardiac biomarkers. Their product portfolio includes rapid antigen tests for COVID-19, influenza A+B, RSV, and dual influenza/COVID-19 testing, as well as fluorescence-based tests for procalcitonin (PCT) and NT-proBNP cardiac markers. These products are designed for rapid results suitable for clinical settings, urgent care, and home testing environments. Nano-Ditech's manufacturing capabilities support both single-analyte and multiplexed diagnostic platforms. The company maintains product catalogs and instructions for use (IFU) documentation available through their website, indicating compliance with regulatory documentation requirements. Their focus on rapid immunodiagnostic innovation positions them as a supplier to hospitals, clinical laboratories, diagnostic distributors, and institutional buyers requiring point-of-care testing solutions for infectious disease screening and cardiac risk stratification.